Rhythm Pharmaceuticals Announces Positive Data with Setmelanotide in Additional MC4R Pathway Deficiency-related Obesities

    NEXT STORY
    Nextech’s InfernoAR Signs Annual License Contract With National Association of Medicaid Directors (NAMD)
    PREV STORY
    Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immunocore announces dosing of first patient with fourth ImmTAC®

    author_avatar
    NASDAQ Market News

    Myriad’s BRACAnalysis CDx® Test Identifies Patients with Newly Diagnosed Advanced Ovarian Cancer Who May Benefit from Maintenance Treatment with Lynparza®

    SALT LAKE CITY, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), ...

    author_avatar
    NASDAQ Market News

    Selecta Biosciences Appoints Dr. Goran Ando to its Board of Directors

    author_avatar
    NASDAQ Market News